Assyro AI

FDA Orange Book · active-ingredient family

Piperacillin sodium

Piperacillin sodium is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:PIPRACIL · NDA 050545

1

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
PIPRACILRLD×4WYETH PHARMS INCNDA 050545Approved Prior to Jan 1, 1982

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
PIPERACILLINISTITUTO BIO ITA SPAANDA 065157Jul 12, 2004
PIPERACILLIN×3ISTITUTO BIO ITA SPAANDA 065114Nov 14, 2003
PIPRACIL×3WYETH PHARMS INCANDA 062750Oct 13, 1987

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Piperacillin sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.